Nicainoprol
Alternative Names: RU 42924Latest Information Update: 13 Dec 1994
At a glance
- Originator Aventis
- Developer Cassella-Riedel
- Class Class I antiarrhythmics; Propanolamines; Small molecules
- Mechanism of Action Beta adrenergic receptor antagonists; Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias